Patients taking Wegovy should monitor for alarm features that suggest more serious pathology: Unintentional weight loss beyond expected therapeutic weight reduction Difficulty swallowing (dysphagia) Persistent vomiting Evidence of gastrointestinal bleeding (black, tarry stools or blood in vomit) Severe, unrelenting abdominal pain, especially if radiating to the back (which may indicate pancreatitis) Right upper abdominal pain with or without fever/jaundice (which may indicate gallbladder disease) If you experience these symptoms whilst taking Wegovy, it is essential to contact your GP promptly for clinical assessment
The regulator is essentially drawing a firm line: Build genuine HCP education and patient outcomes, not consumer-facing hype
Published 2025 Jan 8
The effects of collagen peptide, supplementation on body composition, collagen synthesis, and recovery from joint injury and exercise: systematic review. Khatri, Naughton, Clifford
Statements regarding this product have not been evaluated by the MHRA or any other regulatory authority
Mustafa Ahmed, MD, FACS, FAACS, our practice combines expert knowledge with a personalized approach to weight loss that is as unique as you are